22-30370377-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001017437.5(CCDC157):c.472G>A(p.Glu158Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0005 in 1,614,048 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001017437.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC157 | NM_001017437.5 | c.472G>A | p.Glu158Lys | missense_variant | 5/12 | ENST00000338306.8 | NP_001017437.3 | |
KIAA1656 | NR_046312.1 | n.6039C>T | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC157 | ENST00000338306.8 | c.472G>A | p.Glu158Lys | missense_variant | 5/12 | 5 | NM_001017437.5 | ENSP00000343087 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000500 AC: 76AN: 152142Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000636 AC: 160AN: 251394Hom.: 0 AF XY: 0.000758 AC XY: 103AN XY: 135864
GnomAD4 exome AF: 0.000500 AC: 731AN: 1461788Hom.: 3 Cov.: 31 AF XY: 0.000583 AC XY: 424AN XY: 727192
GnomAD4 genome AF: 0.000499 AC: 76AN: 152260Hom.: 1 Cov.: 33 AF XY: 0.000376 AC XY: 28AN XY: 74442
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.472G>A (p.E158K) alteration is located in exon 5 (coding exon 3) of the CCDC157 gene. This alteration results from a G to A substitution at nucleotide position 472, causing the glutamic acid (E) at amino acid position 158 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at